Endometrial CancerBehavioralWomen's healthBehavioral
What this study is
To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing
What's being tested
- Qualitative interviews
Intervention · BEHAVIORAL
Interviews will be conducted for approximately 45-60 minutes
Study details
- Sponsor
- M.D. Anderson Cancer Center
- Conditions
- Endometrial Cancer
- Enrolling
- 45 people
- Starts
- 2024-06-25
- Est. completion
- 2030-08-30
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex FEMALEHealthy volunteers Not acceptedYou may qualify if
- Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of endometrial cancer
- Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of abnormal uterine bleeding or endometrial hyperplasia
- Women without a diagnosis of endometrial cancer or endometrial hyperplasia
- Women must be at least 18 years or age
- Women must be able to read, write, and speak English
- Women must be willing and able to provide written informed consent
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openMD Anderson Cancer Center
Houston, Texas, United States
- Larissa Meyer Meyer, MD · Contact713-745-0973lmeyer@mdanderson.org
Recruiting
Study team
Sponsor
M.D. Anderson Cancer Center
Study ID 2023-0443
Principal investigator
Larissa Meyer, MD
M.D. Anderson Cancer Center
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.